These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15870100)

  • 1. Impact of UK Colorectal Cancer Screening Pilot on hospital diagnostic services.
    Price J; Campbell C; Sells J; Weller D; Campbell H; Kenicer M; Dunlop M
    J Public Health (Oxf); 2005 Sep; 27(3):246-53. PubMed ID: 15870100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
    Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
    Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of UK colorectal cancer screening pilot on primary care.
    Jepson R; Weller D; Alexander F; Walker J
    Br J Gen Pract; 2005 Jan; 55(510):20-5. PubMed ID: 15667761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Planning for a possible national colorectal cancer screening programme.
    Garvican L
    J Med Screen; 1998; 5(4):187-94. PubMed ID: 9934649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?
    Carlson CM; Kirby KA; Casadei MA; Partin MR; Kistler CE; Walter LC
    Arch Intern Med; 2011 Feb; 171(3):249-56. PubMed ID: 20937917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
    Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
    Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new NHS colorectal cancer screening programme and the potential role of radiology?
    Sahni VA; Burling D
    Br J Radiol; 2007 Oct; 80(958):778-81. PubMed ID: 17959921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom.
    UK Colorectal Cancer Screening Pilot Group
    BMJ; 2004 Jul; 329(7458):133. PubMed ID: 15237087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer screening with double-contrast barium enema: a national survey of diagnostic radiologists.
    Klabunde CN; Jones E; Brown ML; Davis WW
    AJR Am J Roentgenol; 2002 Dec; 179(6):1419-27. PubMed ID: 12438029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The UK colorectal cancer screening pilot: results of the second round of screening in England.
    Weller D; Coleman D; Robertson R; Butler P; Melia J; Campbell C; Parker R; Patnick J; Moss S
    Br J Cancer; 2007 Dec; 97(12):1601-5. PubMed ID: 18026197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for colorectal cancer in Italy: 2005 survey.
    Zorzi M; Barca A; Falcini F; Grazzini G; Pizzuti R; Ravaioli A; Sassoli de Bianchi P; Senore C; Sigillito A; Vettorazzi M; Visioli C
    Epidemiol Prev; 2007; 31(2-3 Suppl 2):49-60. PubMed ID: 17824362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colonoscopy requirements of population screening for colorectal cancer in New Zealand.
    Green T; Richardson A; Parry S
    N Z Med J; 2012 Jun; 125(1356):85-95. PubMed ID: 22729063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer.
    Robinson MH; Hardcastle JD; Moss SM; Amar SS; Chamberlain JO; Armitage NC; Scholefield JH; Mangham CM
    Gut; 1999 Oct; 45(4):588-92. PubMed ID: 10486370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization.
    Miglioretti DL; Rutter CM; Bradford SC; Zauber AG; Kessler LG; Feuer EJ; Grossman DC
    Med Care; 2008 Sep; 46(9 Suppl 1):S91-6. PubMed ID: 18725839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost benefit of early diagnosis of colorectal cancer.
    Bolin TD
    Scand J Gastroenterol Suppl; 1996; 220():142-6. PubMed ID: 8898453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling future capacity needs and spending on colonoscopy in the English bowel cancer screening programme.
    Nnoaham KE; Lines C
    Gut; 2008 Sep; 57(9):1238-45. PubMed ID: 18441004
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.